Title: A 4-Year Observational Clinical Study of 24 Adult Pompe Disease Patients under Alglucosidase Alfa Enzyme Replacement Therapy
Abstract:BACKGROUNDLate-onset Pompe disease is a metabolic myopathy caused by a defi ciency of acid alpha glucosidase and is primarily characterised by progressive muscle weakness and loss of respiratory funct...BACKGROUNDLate-onset Pompe disease is a metabolic myopathy caused by a defi ciency of acid alpha glucosidase and is primarily characterised by progressive muscle weakness and loss of respiratory function.Alglucosidase alfa enzyme replacement therapy (ERT) is a licensed treatment for this condition.Read More